EBD Group

　　EBD集团是全球从事生物科学领域合作的领导机构。从1993年起，生物科技、医药和医疗器械公司开始使用EBD集团的合作会议、科技和服务来鉴别商业机遇、发展战略合作关系实现成功。

　　EBD集团的会议受到多家业内著名公司和国际贸易协会的支持。EBD会议包括：

　　BIO-Europe®和BIO-Europe Spring®，欧洲最大的独立性生命科学合作会议，受到生物科技产业组织 (BIO) 支持

　　BioPharm AmericaTM，发展最快的北美合作会议

　　EuroMedtechTM，EBD集团的新型合作会议，专注于新颖医药科技产业

　　BioEquity Europe，投资者论坛，与BioCentury Publications和BIO合办

　　ChinaBio®合作论坛，中国首届专注于生物科技/医药的合作性会议，与ChinaBio LLC共同举办

　　Partnering for Global Impact®，新的合作会议，向合作伙伴提供创新论坛、支持并生成社会、慈善投资和资金机会

　　Biotech ShowcaseTM，在旧金山的独立论坛，由EBD集团和Demy-Colton生命科学顾问共同举办并向投资者和业务拓展主管作路演

　　partneringONE®作为EBD集团先进的网络合作服务软件，在世界范围内曾多次被第三方会议作为合作引擎采用。除会议之外，EBD集团的顾问还为寻求产品和技术许可和引进的公司提供服务。partnering360®是开放的在线社区，生命科学行业交易商可以常年利用它提高合作经验。除了组织会议，EBD集团顾问为需要转让产品和技术的公司提供手把手帮助。

　　EBD集团在美国和欧洲设有办公机构。

　　EBD Group is the leading partnering firm for the global life science industry. Since its inception in 1993, EBD Group’s mission has been to facilitate the biotech-pharma partnerships that deliver tomorrow’s healthcare treatments to patients worldwide.

　　Biotech, pharma and medical device companies actively leverage EBD Group’s partnering conferences, technology and services to identify new business opportunities and develop the strategic relationships essential to their future success.

　　EBD Group produces seven of its own landmark partnering events, and provides partnering services for dozens of other industry events. These conferences all feature partneringONE®, EBD Group’s powerful networking software that takes partnering productivity to a higher level. Executives from across the biotechnology value chain today rely on partneringONE to efficiently identify new opportunities and start the dealmaking process through focused one-to-one meetings. By generating over 30,000 such partnering meetings annually, partneringONE has become an important catalyst for the growth of the bio-economy.

　　Building on this expertise and with unrivaled access to major players in the life science market, EBD Group’s consultants provide expert hands-on assistance for firms seeking to in- or out-license products and technologies and develop results-oriented partnering strategies.